PlayStation Plus February Games Leaked - IGN Daily Fix February's line-up of games for the PlayStation Plus catalog have leaked online, and include a major PS5 blockbuster. Daemon has all the details ...

uDepartment of Biostatistics, Bristol Myers Squibb, Princeton, NJ, USA vGlobal Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USA wDepartment of Translational Medicine, Bristol ...

Using both PSMA PET and mpMRI before cognitive targeted biopsy improved specificity for clinically significant prostate cancer from 54.6% to 86.3%. For men undergoing evaluation for suspected prostate ...

Many people with prostate cancer experience fatigue as a symptom of the cancer and as a side effect of treatment. In fact, up to 90 percent of men with prostate cancer experience fatigue.

Most prostate cancers become castration-resistant in about two to three years. Castration-resistant prostate cancer grows even when testosterone levels are low. Nonmetastatic castration-resistant ...

Daniel Kelly does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

Always enter the activation code immediately after it appears on your device screen, ensure your internet connection is stable, and sign in with the correct Discovery Plus account to avoid activation ...

Former President Joe Biden has completed a course of radiation therapy after being diagnosed in May with an "aggressive form" of prostate cancer, according to a spokesperson. Biden's daughter Ashley ...

People with diabetes may experience changes in their urinary and digestive health, and research shows there may be different effects on the body impacting the development of prostate cancer. Diabetes ...

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...